BioNTech SE (WBO:BNTX)
€ 108.9 0.6 (0.55%) Market Cap: 26.09 Bil Enterprise Value: 9.63 Bil PE Ratio: 0 PB Ratio: 1.29 GF Score: 62/100

BioNTech SE at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 11, 2021 / 03:50PM GMT
Release Date Price: €87.15 (+7.61%)
Cory William Kasimov
JPMorgan Chase & Co, Research Division - Senior Biotechnology Analyst

Great. Good morning, everyone, from the Virtual JPMorgan Healthcare Conference. My name is Cory Kasimov. I'm the senior large-cap biotech analyst, and it's my pleasure to introduce our next company, BioNTech, and CEO and Co-Founder, Ugur Sahin.

Please note that following this presentation, we will have a Q&A session right here in this Zoom room where you're also able to submit questions via the little blue ask-a-question button in your conference portal.

So with that, Ugur, thank you so much for being here today. Very interested in this discussion. So let me turn things over to you to get started.

Ugur Sahin
BioNTech SE - Co-Founder, CEO & Member of Management Board

Thank you, Cory. Can you hear me?

Cory William Kasimov;Ugur Sahin
JPMorgan Chase & Co, Research Division - Senior Biotechnology Analyst;BioNTech SE - Co-Founder, CEO & Member of

Yes.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot